Pasteur Institute's news

Filter news

Cellules bronchiques humaines infectées par SARS-CoV-2
News
14.04.2022
Santé - Maladies infectieuses
Monoclonal antibody SPK001: potent and broad neutralization activity across all SARS-CoV-2 variants of concern
SPK001, the monoclonal antibody developed by SpikImm, a biotech company founded by the Institut Pasteur and Truffle...
See the news
Back to top